Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oligosaccharide Assembly01:24

Oligosaccharide Assembly

3.5K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
3.5K
Protein Glycosylation01:25

Protein Glycosylation

9.3K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
9.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular Views into the Synthesis and Activation of Flavocytochrome <i>b</i><sub>558</sub> in Phagocytic Cells-Focus on the Role of EROS.

Antioxidants (Basel, Switzerland)·2026
Same author

Enhancing lectin recognition via precise fluorination: Man<sub>5</sub> glycomimetics for targeting DC-SIGN.

Bioorganic chemistry·2026
Same author

Late-stage peptide modification with salicylaldehyde tag enhances affinity for nuclear factor-kappa B essential modulator.

RSC chemical biology·2025
Same author

Toward Glycomimetic Immunomodulators: A Synthetic Dissection of <i>Phocaeicola vulgatus</i> Core Oligosaccharides and Their Recognition by DC-SIGN.

ACS omega·2025
Same author

Antifibrotic Efficacy of a Nintedanib-Peptide Conjugate and Diagnostic Potential of a Fluorescent Companion Probe Targeting α<sub>V</sub>β<sub>6</sub> Integrin in Idiopathic Pulmonary Fibrosis.

ACS pharmacology & translational science·2025
Same author

Interaction studies by NMR on the multivalent interaction between chondroitin sulfate E derivatives and the langerin receptor.

Organic & biomolecular chemistry·2025
Same journal

Novel Dual Soft Drug Strategy Enables Development of Topical Androgen Receptor Antagonists with Enhanced Efficacy and Optimized Safety for Androgenetic Alopecia.

Journal of medicinal chemistry·2026
Same journal

Design, Synthesis, and Biological Evaluation of Novel PAK1/HDAC10 Dual Inhibitors That Activate Antitumor Immunity for Triple-Negative Breast Cancer Treatment.

Journal of medicinal chemistry·2026
Same journal

Conformationally Tuned Cyclic RGD Peptides for Integrin-Subtype-Selective PET/CT Imaging.

Journal of medicinal chemistry·2026
Same journal

RIMTAC: A Novel Degrader Design Platform by Indirect VHL-Recruitment via RIPK1.

Journal of medicinal chemistry·2026
Same journal

Structure-Activity Relationship of Cycling Molecular Assemblies for Golgi Targeting and Disruption.

Journal of medicinal chemistry·2026
Same journal

Rational Design of Diaryl Ether-Based Dual Inhibitors Targeting Successive Essential Enzymes HadAB and InhA in <i>Mycobacterium tuberculosis</i>.

Journal of medicinal chemistry·2026
See all related articles

Related Experiment Video

Updated: Jan 14, 2026

Visualizing Intracellular Sialylation with Click Chemistry and Expansion Microscopy
08:16

Visualizing Intracellular Sialylation with Click Chemistry and Expansion Microscopy

Published on: February 7, 2025

984

Increasing the Chemical Space of L-SIGN Specific Glycomimetics.

Gianluca Cavazzoli1, Clara Delaunay2, Sara Pollastri1

  • 1Dipartimento di Chimica, Università degli Studi di Milano, via Golgi 19, Milano 20133, Italy.

Journal of Medicinal Chemistry
|October 18, 2025
PubMed
Summary
This summary is machine-generated.

Researchers developed new mannose glycomimetics that bind to L-SIGN, a C-type lectin receptor. These compounds show high selectivity for L-SIGN, matching or improving upon previous versions for potential antiviral therapies.

More Related Videos

Metabolic Glycoengineering of Sialic Acid Using N-acyl-modified Mannosamines
12:06

Metabolic Glycoengineering of Sialic Acid Using N-acyl-modified Mannosamines

Published on: November 25, 2017

13.3K
Chemo-enzymatic Synthesis of N-glycans for Array Development and HIV Antibody Profiling
11:08

Chemo-enzymatic Synthesis of N-glycans for Array Development and HIV Antibody Profiling

Published on: February 5, 2018

9.1K

Related Experiment Videos

Last Updated: Jan 14, 2026

Visualizing Intracellular Sialylation with Click Chemistry and Expansion Microscopy
08:16

Visualizing Intracellular Sialylation with Click Chemistry and Expansion Microscopy

Published on: February 7, 2025

984
Metabolic Glycoengineering of Sialic Acid Using N-acyl-modified Mannosamines
12:06

Metabolic Glycoengineering of Sialic Acid Using N-acyl-modified Mannosamines

Published on: November 25, 2017

13.3K
Chemo-enzymatic Synthesis of N-glycans for Array Development and HIV Antibody Profiling
11:08

Chemo-enzymatic Synthesis of N-glycans for Array Development and HIV Antibody Profiling

Published on: February 5, 2018

9.1K

Area of Science:

  • Biochemistry
  • Structural Biology
  • Drug Discovery

Background:

  • C-type lectin receptors like L-SIGN are targets for antiviral therapies and drug delivery.
  • Previous work identified Man84 as a selective L-SIGN ligand with micromolar affinity.
  • High selectivity against homologue lectins, such as DC-SIGN, is crucial.

Purpose of the Study:

  • To design and synthesize novel Man84 isosteres (ligands 2-11) with maintained or improved L-SIGN selectivity.
  • To evaluate the binding affinity and selectivity of these new ligands against L-SIGN and DC-SIGN.
  • To elucidate the structural basis of ligand binding to L-SIGN.

Main Methods:

  • Synthesis of Man84 isosteres (ligands 2-11).
  • Surface Plasmon Resonance (SPR) inhibition assays using immobilized SARS-CoV-2 Spike protein to measure L-SIGN and DC-SIGN binding affinity and selectivity.
  • X-ray crystallography to determine the structure of the L-SIGN CRD/ligand 4 complex.

Main Results:

  • Compounds 4, 5, and 9 demonstrated low micromolar affinity for L-SIGN.
  • These compounds exhibited 50-94 fold selectivity for L-SIGN over DC-SIGN, matching or surpassing Man84.
  • The crystal structure revealed a key bidentate hydrogen bond interaction between ligand 4 and L-SIGN residue E370.

Conclusions:

  • The developed Man84 isosteres represent potent and selective L-SIGN ligands.
  • These findings support the potential of these compounds in antiviral strategies and targeted delivery systems.
  • Structural insights provide a basis for further optimization of L-SIGN targeting ligands.